WUXI BIOLOGICS
WuXi Biologics is a open-access technology platform company offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. Across the global biologics research and development community, we enable our partners to find innovative biological treatments for diseases worldwide.
WUXI BIOLOGICS
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2014-01-01
Status:
Active
Contact:
+86 (510)-8183-1205
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-17 | CMAB BioPharm | CMAB BioPharm acquired by WuXi Biologics | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-19 | Duality Biologics | WuXi Biologics investment in Series B - Duality Biologics | 90 M USD |
| 2020-09-30 | Invetx | WuXi Biologics investment in Series A - Invetx | 10.25 M USD |
| 2020-02-24 | Invetx | WuXi Biologics investment in Series A - Invetx | 15 M USD |
| 2019-05-21 | Inhibrx | WuXi Biologics investment in Convertible Note - Inhibrx | 40 M USD |
| 2019-04-23 | Duoning Biotech | WuXi Biologics investment in Series A - Duoning Biotech | 100 M CNY |